FDA采用自主人工智能,推动人工智能在机构内广泛应用。
FDA adopts agentic AI in latest push to infuse artificial intelligence into agency
生物技术与制药领域的最新动态
FDA adopts agentic AI in latest push to infuse artificial intelligence into agency
MorphoNet 2.0: An innovative approach for qualitative assessment and segmentation curation of large-scale 3D time-lapse imaging datasets
Eed controls craniofacial osteoblast differentiation and mesenchymal proliferation from the neural crest
Keeping track of moving targets
Morgan Stanley assumes coverage on 10X Genomics stock with Equalweight rating - Investing.com
Morgan Stanley assumes coverage on Thermo Fisher stock with Overweight rating - Investing.com
10x Genomics downgraded to Equal Weight from Overweight at Morgan Stanley - TipRanks
Morgan Stanley assumes coverage on 10X Genomics stock with Equalweight rating - Investing.com
10x Genomics assumed at Equal Weight from Overweight at Morgan Stanley - TipRanks
New ACIP chair claims Covid-19 vaccines caused cancer, miscarriages
Janux’s prostate cancer immunotherapy’s response rate drops, according to new early-stage data
FDA and Prasad's Covid vaccine death claims lack key details
Key facts: HSBC Raises Thermo Fisher Price Target to $670; VP Files to Sell Shares - TradingView
Regeneron makes $150M bet on Tessera's rare disease gene writing prospect
European Union teams up with Angelini to funnel €150M to European health startups
Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts - ts2.tech
Belite Bio aims for first approval of Stargardt disease treatment with Phase 3 success
UK agrees to boost drug prices to dodge US pharma tariffs
Appointments and advancements for Dec. 1, 2025
Financings for Dec. 1, 2025